查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954676

全球辐射剂量管理市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Radiation Dose Management Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

辐射剂量管理市场的成长驱动因素

全球辐射剂量管理市场正经历显着成长，其成长动力主要来自诊断影像程序的增加、日益严格的病患安全法规以及先进辐射技术的广泛应用。根据2025年报告分析，2025年全球市场规模为8.542亿美元，预计2026年将成长至9.733亿美元。预计2026年至2034年，该市场将以15.10%的强劲年复合成长率成长，到2034年达到30.04亿美元。

北美在2025年占据全球市场主导地位，市场占有率达39.10%，这得益于其完善的监管框架、高诊断成像量以及对先进剂量监测软体的早期应用。

市场概览

辐射剂量管理是指目的是监测、追踪和最佳化医学影像诊断过程（例如CT扫描、X光、透视和核子医学检查）中辐射暴露的解决方案和软体系统。这些系统帮助医疗机构在确保符合安全准则的前提下，获得高品质的诊断影像。

全球诊断影像程序数量的不断成长以及人们对辐射相关健康风险日益增强的认识，是推动剂量管理解决方案需求的主要因素。主要产业参与者之间的策略联盟进一步加速市场扩张。例如，领先企业与剂量管理解决方案提供者之间的合作促进技术整合和工作流程最佳化。

新冠疫情的影响

新冠疫情对辐射剂量管理市场产生了正面影响。用于新冠病毒诊断的CT扫描激增，导致全球诊断影像量显着增加。由于CT影像使用电离辐射，医院加快了剂量监测解决方案的采用，以确保病患安全和符合监管要求。

CT扫描使用量的增加带动了影像设备销售的成长，进而推动了对整合辐射剂量管理软体的需求。市场在2022年全面復苏，此后一直保持强劲的成长动力。

主要市场趋势

人工智慧（AI）的整合

影响市场发展的关键趋势之一是将人工智慧（AI）整合到放射学领域。 AI 演算法有助于：

  • 最佳化影像处理方案
  • 改进影像重建
  • 预测每位病患的辐射暴露量
  • 增强风险预测模型

随着 AI 的不断发展，剂量最佳化策略和个人化成像方法的支援预计将进一步改进，这将显着推动市场成长，直至2034年。

市场成长驱动因素

1.严格的辐射安全法规

国际原子能总署（IAEA）等国际组织和欧洲监管机构已製定了严格的电离辐射安全标准。为减少不必要的辐射暴露，特别是孕妇和儿童等弱势群体的辐射暴露，监管压力不断加大，这推动了剂量管理软体的普及应用。

2.影像技术的进步

CT 扫描仪、迭代重建演算法和影像软体的持续进步，在提高影像品质的同时，也降低了辐射暴露。供应商发布升级版的剂量管理平台，这些平台具备更强大的分析和监测功能，加速市场渗透。

限制因子

儘管成长前景广阔，但仍存在以下挑战：

  • 影像系统和剂量管理软体成本高昂
  • 中低收入国家医疗基础设施不足
  • 小型医院和诊断中心预算有限

在许多发展中地区，电力供应不足和成像设施的限制阻碍了大规模部署。

市场区隔分析

依手术类型

市场区隔如下：

  • 电脑断层扫描（CT）
  • 核子医学
  • X射线和乳房X光检查
  • 透视与介入治疗影像
  • 其他

X光检查。乳房X光检查占据最大的市场占有率，预计到2026年将占市场占有率的40.46%，这主要得益于X光检查和乳癌筛检的增加。

预计核医领域将以最高的年复合成长率成长，这主要得益于全球PET和SPECT扫描数量的不断成长。

依应用领域划分

主要应用领域如下：

  • 肿瘤科
  • 骨科
  • 心臟科
  • 神经科
  • 其他

预计到2026年，骨科领域将占据最大的市场占有率，达到36.64%，这主要得益于创伤病例和运动损伤病例的增加，这些病例需要透视引导手术。

预计肿瘤科领域将实现最高的年复合成长率，这主要得益于癌症诊断和追踪中重复CT扫描需求的不断成长。

依最终使用者划分

市场区隔如下：

  • 医院和专科诊所
  • 诊断中心
  • 其他

预计到2026年，诊断中心细分市场将以49.60%的市场占有率引领市场，并在2034年之前维持最高的年复合成长率，这主要得益于门诊影像检查数量的增加。

区域洞察

北美

北美维持了其市场领先地位，2025年市场规模达到3.339亿美元。预计到2026年，美国市场规模将达3.61亿美元。这一成长得益于核医学检查的高水准开展以及强有力的监管执行。

欧洲

到2025年，欧洲占据第二大市场占有率，这主要得益于辐射安全训练的加强和监管举措的推进。德国和英国是该地区成长的主要贡献者。

亚太地区

预计到2034年，亚太地区将以最高的年复合成长率成长。该地区的成长主要得益于医疗基础设施的扩张和医疗支出的增加。

  • 预计2026年，日本市场规模将达到1.085亿美元。
  • 预计2026年，中国市场规模将达到8,570万美元。
  • 预计到2026年，印度市场规模将达到4,230万美元。

其他地区（ROW）

由于基础设施不足和医疗支出较低，其他地区的成长速度相对较慢。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要发现

  • 2025年主要国家和地区的电脑断层扫描（CT）扫描量
  • 2025年主要国家和地区的磁振造影（MRI）扫描量
  • 主要产业趋势（併购、合作、新产品发表等）
  • 新冠疫情的影响市场

第5章 全球辐射剂量管理市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依手术类型划分
    • 电脑断层扫描（CT）
    • 核子医学
    • X射线和乳房X光检查
    • 透视与介入性影像
    • 其他
  • 市场分析、洞察与预测：依应用领域划分
    • 肿瘤科
    • 骨科
    • 心臟科
    • 神经科
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和专科诊所
    • 诊断中心
    • 其他
  • 市场分析、洞察与预测预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美辐射剂量管理市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲辐射剂量管理市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲地区

第8章 分析亚太地区辐射剂量管理市场：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 其他亚太地区

第9章 拉丁美洲辐射剂量管理市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第10章 中东与非洲辐射剂量管理市场分析：洞察与预测（2021-2034）

  • 各国概览
    • GCC
    • 南非
    • 其他中东和非洲国家

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • Bayer AG
    • Siemens Healthineers AG
    • FUJIFILM Corporation
    • GE Healthcare
    • Koninklijke Philips N.V.
    • Bracco
    • Medsquare SAS
Product Code: FBI101228

Growth Factors of radiation dose management Market

The global radiation dose management market is witnessing significant growth driven by rising imaging procedures, strict patient safety regulations, and increasing adoption of advanced radiology technologies. According to the 2025 report analysis, the market was valued at USD 854.2 million in 2025 and is projected to grow to USD 973.3 million in 2026. The market is expected to reach USD 3,004.00 million by 2034, expanding at a robust CAGR of 15.10% during 2026-2034.

North America dominated the global market with a 39.10% share in 2025, supported by strong regulatory frameworks, high imaging volumes, and early adoption of advanced dose monitoring software.

Market Overview

Radiation dose management refers to solutions and software systems designed to monitor, track, and optimize radiation exposure during medical imaging procedures such as CT scans, radiography, fluoroscopy, and nuclear medicine. These systems help healthcare providers maintain compliance with safety guidelines while ensuring high-quality diagnostic imaging.

The growing number of imaging procedures globally, combined with increasing awareness of radiation-related health risks, is a primary factor fueling demand for dose management solutions. Strategic collaborations among key industry players are further strengthening market expansion. For instance, partnerships between leading imaging companies and dose management solution providers are accelerating technological integration and workflow optimization.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the radiation dose management market. The surge in CT scans for diagnosing COVID-19 significantly increased imaging volumes worldwide. Since CT imaging involves ionizing radiation, hospitals increasingly adopted dose monitoring solutions to ensure patient safety and regulatory compliance.

Higher CT utilization led to increased sales of imaging equipment, which in turn drove demand for integrated radiation dose management software. The market fully recovered by 2022 and has since resumed strong growth momentum.

Key Market Trends

Integration of Artificial Intelligence (AI)

A major trend shaping the market is the integration of Artificial Intelligence (AI) in radiology. AI-powered algorithms help:

  • Optimize imaging protocols
  • Improve image reconstruction
  • Predict patient-specific radiation doses
  • Enhance risk prediction models

As AI continues to evolve, it is expected to further improve dose optimization strategies and support personalized imaging approaches, significantly strengthening market growth through 2034.

Market Growth Drivers

1. Stringent Radiation Safety Regulations

Global organizations such as the International Atomic Energy Agency (IAEA) and European regulatory bodies have established strict safety standards for ionizing radiation. Growing regulatory pressure to reduce unnecessary radiation exposure-especially among vulnerable populations such as pregnant women and children-is driving widespread adoption of dose management software.

2. Technological Advancements in Imaging

Continuous advancements in CT scanners, iterative reconstruction algorithms, and imaging software are improving image quality while reducing radiation exposure. Vendors are launching upgraded versions of dose management platforms with enhanced analytics and monitoring capabilities, accelerating market penetration.

Restraining Factors

Despite strong growth prospects, certain challenges persist:

  • High costs associated with imaging systems and dose management software
  • Limited healthcare infrastructure in low- and middle-income countries
  • Budget constraints in smaller hospitals and diagnostic centers

In many developing regions, insufficient electricity supply and limited imaging facilities hinder large-scale adoption.

Market Segmentation Analysis

By Procedure

The market is segmented into:

  • Computed Tomography (CT)
  • Nuclear Medicine
  • Radiography & Mammography
  • Fluoroscopy & Interventional Imaging
  • Others

The Radiography and Mammography segment held the largest share and is expected to account for 40.46% of the market in 2026, driven by rising X-ray and breast cancer screening procedures.

The Nuclear Medicine segment is projected to grow at the highest CAGR due to increasing PET and SPECT scan volumes globally.

By Application

Key application areas include:

  • Oncology
  • Orthopedics
  • Cardiology
  • Neurology
  • Others

The Orthopedics segment held the largest share, accounting for 36.64% in 2026, supported by increasing trauma cases and sports injuries requiring fluoroscopic guidance.

The Oncology segment is anticipated to register the highest CAGR due to the growing need for repetitive CT scans for cancer diagnosis and monitoring.

By End User

The market is categorized into:

  • Hospitals & Specialty Clinics
  • Diagnostic Centers
  • Others

The Diagnostic Centers segment dominated with a 49.60% share in 2026 and is expected to grow at the highest CAGR through 2034, driven by increasing outpatient imaging volumes.

Regional Insights

North America

North America generated USD 333.9 million in 2025, maintaining market leadership. The U.S. market is projected to reach USD 361 million in 2026. Growth is supported by high nuclear medicine procedure volumes and strong regulatory enforcement.

Europe

Europe held the second-largest share in 2025, driven by increasing radiation safety training and regulatory initiatives. Germany and the UK are major contributors to regional growth.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034. The region's growth is fueled by expanding healthcare infrastructure and rising healthcare expenditure.

  • Japan market expected to reach USD 108.5 million in 2026
  • China market projected at USD 85.7 million in 2026
  • India market estimated at USD 42.3 million in 2026

Rest of the World

Growth remains comparatively slower due to limited infrastructure and lower healthcare spending.

Competitive Landscape

Major players operating in the radiation dose management market include:

  • Siemens Healthineers AG
  • FUJIFILM Corporation
  • GE Healthcare
  • Bayer AG
  • Koninklijke Philips N.V.
  • Bracco
  • Medsquare SAS

These companies maintain strong positions through diversified product portfolios, technological innovation, strategic partnerships, and geographic expansion.

Conclusion

The global radiation dose management market is poised for strong expansion from USD 854.2 million in 2025 to USD 3,004.00 million by 2034, driven by increasing imaging volumes, AI integration, regulatory compliance requirements, and technological advancements. While cost and infrastructure challenges remain in developing regions, growing awareness of radiation safety and expanding diagnostic capabilities worldwide will continue to propel long-term market growth.

Segmentation By Procedure

  • Computed Tomography
  • Nuclear Medicine
  • Radiography and Mammography
  • Fluoroscopy and Interventional Imaging
  • Others

By Application

  • Oncology
  • Orthopedics
  • Cardiology
  • Neurology
  • Others

By End-user

  • Hospitals & Specialty Clinics
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Procedure, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Procedure, By Application, By End-user, and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Procedure, By Application, By End-user, and By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Procedure, By Application, and By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Computed tomography (CT) Exams, Key Countries/ Regions, 2025
  • 4.2. Number of Magnetic Resonance Imaging (MRI) Exams, Key Countries/ Regions, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  • 4.4. Impact of COVID-19 in the Market

5. Global Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Procedure
    • 5.1.1. Computed Tomography
    • 5.1.2. Nuclear Medicine
    • 5.1.3. Radiography and Mammography
    • 5.1.4. Fluoroscopy and Interventional Imaging
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Oncology
    • 5.2.2. Orthopedics
    • 5.2.3. Cardiology
    • 5.2.4. Neurology
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & Specialty Clinics
    • 5.3.2. Diagnostic Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Procedure
    • 6.1.1. Computed Tomography
    • 6.1.2. Nuclear Medicine
    • 6.1.3. Radiography and Mammography
    • 6.1.4. Fluoroscopy and Interventional Imaging
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Oncology
    • 6.2.2. Orthopedics
    • 6.2.3. Cardiology
    • 6.2.4. Neurology
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & Specialty Clinics
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Procedure
    • 7.1.1. Computed Tomography
    • 7.1.2. Nuclear Medicine
    • 7.1.3. Radiography and Mammography
    • 7.1.4. Fluoroscopy and Interventional Imaging
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Oncology
    • 7.2.2. Orthopedics
    • 7.2.3. Cardiology
    • 7.2.4. Neurology
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & Specialty Clinics
    • 7.3.2. Diagnostic Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Procedure
    • 8.1.1. Computed Tomography
    • 8.1.2. Nuclear Medicine
    • 8.1.3. Radiography and Mammography
    • 8.1.4. Fluoroscopy and Interventional Imaging
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Oncology
    • 8.2.2. Orthopedics
    • 8.2.3. Cardiology
    • 8.2.4. Neurology
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Procedure
    • 9.1.1. Computed Tomography
    • 9.1.2. Nuclear Medicine
    • 9.1.3. Radiography and Mammography
    • 9.1.4. Fluoroscopy and Interventional Imaging
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Oncology
    • 9.2.2. Orthopedics
    • 9.2.3. Cardiology
    • 9.2.4. Neurology
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & Specialty Clinics
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Procedure
    • 10.1.1. Computed Tomography
    • 10.1.2. Nuclear Medicine
    • 10.1.3. Radiography and Mammography
    • 10.1.4. Fluoroscopy and Interventional Imaging
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Oncology
    • 10.2.2. Orthopedics
    • 10.2.3. Cardiology
    • 10.2.4. Neurology
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & Specialty Clinics
    • 10.3.2. Diagnostic Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Bayer AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Product
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Product
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. FUJIFILM Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Product
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. GE Healthcare
      • 11.2.4.1. Overview
      • 11.2.4.2. Product
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Koninklijke Philips N.V.
      • 11.2.5.1. Overview
      • 11.2.5.2. Product
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. Bracco
      • 11.2.6.1. Overview
      • 11.2.6.2. Product
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. Medsquare SAS
      • 11.2.7.1. Overview
      • 11.2.7.2. Product
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 2: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 3: Global Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 6: North America Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 7: North America Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Radiation Dose Management Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 10: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 11: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 14: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 18: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 19: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 22: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Radiation Dose Management Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Radiation Dose Management Market Value Share (%), by Procedure, 2025 & 2034
  • Figure 3: Global Radiation Dose Management Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Radiation Dose Management Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Radiation Dose Management Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 7: North America Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 8: North America Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 9: North America Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 10: North America Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 12: North America Radiation Dose Management Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Radiation Dose Management Market Value Share (%), By Country, 2025
  • Figure 14: Europe Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 15: Europe Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 16: Europe Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 17: Europe Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 18: Europe Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 23: Asia Pacific Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 24: Asia Pacific Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 31: Latin America Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 32: Latin America Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 33: Latin America Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 39: Middle East & Africa Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 40: Middle East & Africa Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Radiation Dose Management Market Share (%), By Company, 2025